Indication
Treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.
Loading your page…
Loading your page…
Corneal Diseases
Marketing Authorisation Holder: Santen Oy
EMA Authorisation: 19/03/2015
INN: ciclosporin
AI Drug & Interaction Analysis
Free account required
Ask Osler about Ikervis: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.